Trial Profile
A phase I study of TEV 90112 for the treatment of human immunodeficiency virus (HIV) infections
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 02 Dec 2014
Price :
$35
*
At a glance
- Drugs TEV 90112 (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 02 Dec 2014 New trial record